Search

everythinglearnresearchcommunity

for

Search:↓

Dermal Papilla cells are a promising tool for evaluating hair growth treatments.

Finasteride is a safe, effective treatment for hirsutism with fewer side effects.

Finasteride, CPA, and flutamide are all equally effective in reducing excessive hair growth in women.

New genes and pathways are important for testosterone production and male sexual development.

SHBG may be a useful early indicator and treatment target for PCOS.

Antiandrogens, particularly flutamide and CPA, are most effective for treating hirsutism, with long-term use needed for best results.

FOXN1 gene variants cause low T cells and immune issues from birth.

The skin's ability to produce hormones is linked to various skin conditions, and better understanding this process could lead to new treatments.

Weight loss and metformin don't significantly change vaspin levels in women with PCOS.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Hirsutism is excessive male-pattern hair growth in women, often caused by hormonal imbalances, and requires ongoing treatment to manage.

CD98hc's role in skin health decreases with age.

Hormone treatments can help with women's skin and hair disorders, but they need careful monitoring and more research.

Some hormone-related drugs may protect brain cells in Parkinson's disease differently in men and women.

Certain 4-azasteroids are effective at blocking the enzyme that processes testosterone in human skin and could help treat acne, excessive hair growth, and male pattern baldness.

Finasteride and flutamide both reduce hair growth, but finasteride has fewer side effects.

Certain HSD3B1 gene types are linked to worse prostate cancer outcomes and affect treatment response and other health conditions.

The document concludes that managing hirsutism involves identifying the cause, using a scoring system for severity, combining cosmetic and medical treatments, encouraging weight loss, and providing psychological support, while noting the need for more research on drug treatments.

Recent genetic insights show that low-renin hypertension includes a range from essential hypertension to secondary or familial forms, affecting diagnosis and treatment.

SHBG binding properties are unchanged in male liver cirrhosis patients.

Using anabolic androgenic steroids can cause serious, lasting health problems in many parts of the body.

All treatments reduce hair growth; low dose flutamide most effective with fewer side effects.

DHEA may help with sexual function when used intravaginally by menopausal women but is similar to hormone therapy in other aspects and might cause more side effects like acne and hair loss.

Effective hirsutism management requires identifying the cause, combining new and traditional treatments, and setting realistic expectations for patients.

Estrogen increases blood vessel growth factor production, while testosterone blocks this increase.

New pregnane derivatives were more effective than finasteride at inhibiting a key enzyme for male pattern baldness.

Dihydrotestosterone causes p27 protein breakdown in ovarian and breast cancer cells by binding with SKP2.

The study found that urine metabolites M1b or M4 are the best indicators of ATD use in horses, with detection possible up to 77 hours in urine and 28 hours in blood.

The new FDA labeling rules provide more detailed drug safety information for pregnant and breastfeeding women, but more data is needed on the risks of many dermatologic drugs.

Testosterone significantly affects sexual desire in both men and women, but its impact on women is more complex and influenced by psychological factors.